Regional Anesthesia in Hip Arthroscopy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to determine differences in outcomes in patients who receive regional anesthesia (a fascia iliaca block) versus placebo prior to undergoing hip arthroscopy with labral repair and/or debridement and osteoplasty for hip impingement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of Regional Anesthesia in Hip Arthroscopy

NCT02851888

Hip Injuries

UNKNOWN PHASE4

Effectiveness of Fascia Iliaca Nerve Block for Post Hip Arthroscopy

NCT02717728

Hip Surgery Corrective Anesthesia; Functional

WITHDRAWN PHASE3

A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy

NCT02623361

Muscle Weakness | Patient Pain

COMPLETED PHASE4

Preemptive Femoral & Lateral Femoral Cutaneous Nerve Blocks for THA Acute Pain

NCT01997567

Internal Derangement of Hip Acetabular Labrum Tear

TERMINATED NA

Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy

NCT02882633

Hip Arthroscopy Nerve Block

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methods: After informed consent is obtained at a routine/pre-surgical clinic visit, all patients who meet eligibility criteria will undergo randomization into one of two groups. These groups are 1) to receive regional anesthesia (a single shot fascia iliaca block using bupivacaine) prior to hip arthroscopy, or 2) undergo a subcutaneous injection procedure using a normal saline placebo (0.9% sodium chloride in water) instead of bupivacaine. Intra-operatively, both groups will receive general anesthesia and local anesthesia (lidocaine and bupivacaine in the peripheral compartment).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoroacetabular Impingement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

regional anesthesia bupivacaine

regional anesthesia (a single shot fascia iliaca block using bupivacaine) prior to hip arthroscopy

Group Type ACTIVE_COMPARATOR

regional anesthesia bupivacaine

Intervention Type DRUG

a single shot fascia iliaca block using bupivacaine prior to hip arthroscopy

regional anesthesia placebo

subcutaneous injection procedure placebo (0.9% sodium chloride in water)

Group Type PLACEBO_COMPARATOR

regional anesthesia placebo

Intervention Type DRUG

subcutaneous injection procedure using a normal saline placebo (0.9% sodium chloride in water)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

regional anesthesia bupivacaine

a single shot fascia iliaca block using bupivacaine prior to hip arthroscopy

Intervention Type DRUG

regional anesthesia placebo

subcutaneous injection procedure using a normal saline placebo (0.9% sodium chloride in water)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Exparel Sensorcaine Marcaine Sodium Chloride Injection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient undergoing primary hip arthroscopy with labral repair and osteoplasty for hip impingement
* Age 18-45 years old
* Not pregnant
* No history of neuropathic pain
* No radiographic signs of osteoarthritis of the operative hip (Tönnisgrade 1)
* Willing and able to comply with post-operative hip arthroscopy protocol
* No documented allergy to anesthetic agents
* Able to attend follow up appointments

Exclusion Criteria

* Allergy to regional anesthetic
* Age \<18 or \>45 years
* Pregnant females
* History of neuropathic pain
* Radiographic signs of osteoarthritis (Tönnis grade 2)
* Unable to speak/understand English
* Currently imprisoned
* Unwilling/unable to provide consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes